PTEN and ovarian carcinoma: While there is no doubt that genetic alterations in PIK3CA, and AKT, or the loss of PTEN contribute to the role of the PI3K/AKT/mTOR pathway in the progression of ovarian cancer, this study suggests that that there are additional important factors that drive the PI3K pathway [73].